Skip to main content
. 2014 Sep 16;2014:297458. doi: 10.1155/2014/297458

Table 2.

Changes in muscle strength, VAS, and Lequesne index scores from baseline to 12 weeks in the non-GEJ-treated group and the GEJ-treated group.

Variables Non-GEJ-treated group (n = 21) GEJ-treated group (n = 21) P-value
Median P 25 P 75 Median P 25 P 75
Incremental changes in muscle strength
 PeakTQ-ext-nondominant (Nm) 2.10 −4.80 14.30 17.70 3.90 28.20 0.090
 PeakTQ-ext-dominant (Nm) 4.60 −1.60 11.70 14.80 3.30 23.20 0.105
 PeakTQ-flex-nondominant (Nm) 3.30 −3.40 8.20 2.90 −1.20 10.20 0.308
 PeakTQ-flex-dominant (Nm) 3.70 −1.40 8.80 2.80 −2.40 10.60 0.870
 TQ/BW-ext-nondominant (ft·lb/lb) 4.70 −2.60 26.60 29.70 6.90 51.30 0.080
 TQ/BW-ext-dominant (ft·lb/lb) 6.10 −2.90 20.40 29.30 6.00 37.30 0.063
 TQ/BW-flex-nondominant (ft·lb/lb) 5.20 −6.00 11.60 4.90 −1.80 17.90 0.308
 TQ/BW-flex-dominant (ft·lb/lb) 6.20 −2.50 12.70 4.80 −3.70 16.40 0.811
Levels of muscle strength of the two groups pre- and posttreatment
 TQ/BW-ext-dominant-pretreatment (ft·lb/lb) 34.80 18.20 77.10 57.80 27.40 82.40 0.365
 TQ/BW-ext-dominant-posttreatment (ft·lb/lb) 50.20 26.50 70.00 87.10 58.90 99.40 0.012∗
 TQ/BW-flex-dominant-pretreatment (ft·lb/lb) 25.50 17.90 46.10 37.30 24.20 53.80 0.204
 TQ/BW-flex-dominant-posttreatment (ft·lb/lb) 27.50 18.30 52.30 47.50 38.20 58.60 0.045∗
 Decremental change of visual analog pain scale score 0.00 −1.00 0.00 0.00 0.00 2.00 0.001∗∗
 Decremental change of Lequesne index score −1.00 −3.00 0.00 2.00 1.00 4.00 0.0003∗∗
  (I) change of pain or discomfort 0.00 −1.00 0.00 1.00 0.00 2.00 0.002∗∗
  (II) change of maximum distance walked 0.00 −1.00 0.00 0.00 0.00 1.00 0.003∗∗
  (III) change of activities of daily living 0.00 −1.00 0.00 1.00 0.00 2.00 0.025∗

Mann-Whitney U test; ∗P < 0.05, ∗∗P < 0.01.